When the Roadmap to the EU’s Pharmaceutical strategy was announced by Health Commissioner Stella Kyriakides, she underlined that “The EU needs a pharmaceutical strategy that makes essential medicines available to all and cements our global leadership on innovation in pharmaceuticals”. Now more than ever before, the COVID-19 crisis has shown that the world looks to medical innovation to fight global health threats and to tackle our existing health challenges. In its current form, the pharma strategy roadmap lacks the necessary drivers of innovation to put Europe back at the forefront of medical discovery.
Read more
Treatment Outcomes 2020/30
This international conference, organized under the patronage of the Presidency of the Council of the European Union,...
Read more
The European Commission has officially granted market authorisation for an IMI-supported Ebola vaccine regimen, which...
Read more
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.